Camp4 Director Richard Young Purchases Shares in Private Placement at $1.65

Rhea-AI Filing Summary

Camp4 Therapeutics director Richard A. Young acquired 15,151 shares of Camp4 Therapeutics Corp (CAMP) in a private placement on 09/11/2025 at $1.65 per share under a Securities Purchase Agreement dated 09/09/2025. After this purchase the reporting person beneficially owned 170,010 shares. The Form 4 was filed individually and executed by an attorney-in-fact. The filing states the purchase involved institutional investors and certain directors, employees and consultants; no derivative transactions or other securities changes are reported.

Positive

• Director increased direct ownership to 170,010 shares, indicating continued insider investment
• Purchase executed at a disclosed price of $1.65 per share under a Securities Purchase Agreement

Negative

• None.

Insights

Securities Analyst

TL;DR: An insider director purchased additional equity via a priced private placement, increasing direct beneficial ownership to 170,010 shares.

The transaction is a straightforward non-derivative purchase at $1.65 per share executed under a Securities Purchase Agreement that involved institutional and insider participants. This increases the director's direct stake and aligns ownership with other participants in a private placement. The filing contains no option exercises, dispositions, or changes to derivative holdings and was filed by one reporting person.

Corporate Governance Expert

TL;DR: Director participation in a private placement suggests alignment with financing terms but is routine for insiders.

The Form 4 documents a routine insider purchase disclosed under Section 16. The report identifies the director relationship and confirms the instrument and price but provides no additional governance actions or related-party terms. Material details such as total placement size attributable to insiders or lock-up terms are not included in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Young Richard A

(Last) (First) (Middle)

C/O CAMP4 THERAPEUTICS CORPORATION

ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL.

(Street)

CAMBRIDGE MA 02139

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Camp4 Therapeutics Corp [ CAMP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		P		15,151	A	$1.65(1)	170,010	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.

Remarks:

	/s/ Josh Mandel-Brehm, as Attorney-in-Fact	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Richard A. Young report on Form 4 for CAMP?

He reported acquiring 15,151 shares on 09/11/2025 at $1.65 per share, bringing his beneficial ownership to 170,010 shares.

Was the CAMP Form 4 transaction a sale or an acquisition?

It was an acquisition (transaction code P) of common stock in a private placement.

Under what agreement were the CAMP shares purchased?

The shares were purchased pursuant to a Securities Purchase Agreement dated 09/09/2025 involving institutional investors and certain directors, employees, and consultants.

Did the Form 4 report any derivative transactions for CAMP?

No. The filing shows no derivative securities acquired, disposed of, or beneficially owned.

Was the Form 4 filed jointly or by one reporting person?

The Form 4 was filed by one reporting person (individual filing).